✦ LIBER ✦

Cost-effectiveness of vaccination against cervical cancer: A multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios

✍ Scribed by Eugenio Suárez; Jennifer S. Smith; F. Xavier Bosch; Pekka Nieminen; Chien-Jen Chen; Saku Torvinen; Nadia Demarteau; Baudouin Standaert

Book ID: 116960647
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 899 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.05.069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A generally applicable cost-effectivenes

A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer

✍ Nadia Demarteau; Bruno Detournay; Bertrand Tehard; Abdelkader El Hasnaoui; Baudo 📂 Article 📅 2010 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 352 KB

## Objective This study aimed at evaluating the cost-effectiveness of human papillomavirus virus (HPV) vaccination in France, using a generally applicable succinct cohort model. ## Methods A lifetime Markov cohort model, adapted to the French setting, simulate the natural history of oncogenic HPV

Optimization of primary and secondary ce

Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: A multi-regional health economic analysis

✍ Raina M. Rogoza; Nicole Ferko; James Bentley; Chris J.L.M. Meijer; Johannes Berk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 737 KB

A cost-effectiveness analysis of adding

A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program

✍ Kulasingam, Shalini; Connelly, Luke; Conway, Elizabeth; Hocking, Jane S.; Myers, 📂 Article 📅 2007 🏛 Commonwealth Scientific and Industrial Research Or 🌐 English ⚖ 168 KB

PIH22 EVALUATING THE COST-EFFECTIVENESS

PIH22 EVALUATING THE COST-EFFECTIVENESS OF CERVICAL CANCER SCREENING AND HUMAN PAPILLOMAVIRUS VACCINATION STRATEGIES USING A MATHEMATICAL MODEL

✍ DC Taylor; V Pawar; K Gilmore; M Sanon; D Kruzikas; M Kohli; B Arondekar; N Dema 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Inclusion of the benefits of enhanced cr

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

✍ Tjalke A Westra, Irina Stirbu-Wagner, Sara Dorsman… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 486 KB

PIN23 COST-EFFECTIVENESS ANALYSIS OF THE

PIN23 COST-EFFECTIVENESS ANALYSIS OF THE IMPLEMENTATION OF A QUADRIVALENT (6,1 1, 16,18 TYPES) HUMAN PAPILLOMAVIRUS VACCINE TO THE EXISTING BELGIAN CERVICAL CANCER SCREENING PROGRAMME

✍ L Annemans; V Remy; N Largeron 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB